Follow
Thalia Farazi
Thalia Farazi
Medical Director, Juno Therapeutics A Celgene Company
Verified email at junotherapeutics.com
Title
Cited by
Cited by
Year
miRNAs in human cancer
TA Farazi, JI Spitzer, P Morozov, T Tuschl
The Journal of pathology 223 (2), 102-115, 2011
11432011
MicroRNAs in human cancer
TA Farazi, JI Hoell, P Morozov, T Tuschl
MicroRNA cancer regulation: advanced concepts, bioinformatics and systems …, 2013
8892013
The biology and enzymology of proteinN-myristoylation* 210
TA Farazi, G Waksman, JI Gordon
Journal of biological chemistry 276 (43), 39501-39504, 2001
6972001
The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members
TA Farazi, SA Juranek, T Tuschl
Oxford University Press for The Company of Biologists Limited 135 (7), 1201-1214, 2008
5092008
MicroRNA sequence and expression analysis in breast tumors by deep sequencing
TA Farazi, HM Horlings, JJ Ten Hoeve, A Mihailovic, H Halfwerk, ...
Cancer research 71 (13), 4443-4453, 2011
4212011
RNA targets of wild-type and mutant FET family proteins
JI Hoell, E Larsson, S Runge, JD Nusbaum, S Duggimpudi, TA Farazi, ...
Nature structural & molecular biology 18 (12), 1428-1431, 2011
4022011
Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function
E Karaca, S Weitzer, D Pehlivan, H Shiraishi, T Gogakos, T Hanada, ...
Cell 157 (3), 636-650, 2014
2142014
Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs
RS Bhatnagar, K Fütterer, TA Farazi, S Korolev, CL Murray, ...
nature structural biology 5 (12), 1091-1097, 1998
1611998
Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing
M Hafner, N Renwick, TA Farazi, A Mihailović, JTG Pena, T Tuschl
Methods 58 (2), 164-170, 2012
1422012
A Role for Saccharomyces cerevisiae Fatty Acid Activation Protein 4 in Regulating ProteinN-Myristoylation during Entry into Stationary Phase
K Ashrafi, TA Farazi, JI Gordon
Journal of Biological Chemistry 273 (40), 25864-25874, 1998
1141998
PAR-CLIP (Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation): a step-by-step protocol to the transcriptome-wide identification of binding sites of …
J Spitzer, M Hafner, M Landthaler, M Ascano, T Farazi, G Wardle, ...
Methods in enzymology 539, 113-161, 2014
1132014
Structures of Saccharomyces cerevisiae N-myristoyltransferase with Bound MyristoylCoA and Peptide Provide Insights about Substrate Recognition and Catalysis
TA Farazi, G Waksman, JI Gordon
Biochemistry 40 (21), 6335-6343, 2001
872001
Safety and preliminary efficacy in patients with relapsed/refractory mantle cell lymphoma receiving lisocabtagene maraleucel in transcend NHL 001
ML Palomba, LI Gordon, T Siddiqi, JS Abramson, M Kamdar, MA Lunning, ...
Blood 136, 10-11, 2020
782020
Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets
TA Farazi, JJ Ten Hoeve, M Brown, A Mihailovic, HM Horlings, ...
Genome biology 15, 1-15, 2014
752014
Bioinformatic analysis of barcoded cDNA libraries for small RNA profiling by next-generation sequencing
TA Farazi, M Brown, P Morozov, JJ Ten Hoeve, IZ Ben-Dov, V Hovestadt, ...
Methods 58 (2), 171-187, 2012
732012
Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5′-monophosphate dehydrogenase
T Farazi, J Leichman, T Harris, M Cahoon, L Hedstrom
Journal of Biological Chemistry 272 (2), 961-965, 1997
611997
Deciphering human ribonucleoprotein regulatory networks
N Mukherjee, HH Wessels, S Lebedeva, M Sajek, M Ghanbari, A Garzia, ...
Nucleic acids research 47 (2), 570-581, 2019
602019
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies
AE Place, K Goldsmith, JP Bourquin, ML Loh, L Gore, DA Morgenstern, ...
Future Oncology 14 (21), 2115-2129, 2018
582018
Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets
TA Farazi, CS Leonhardt, N Mukherjee, A Mihailovic, S Li, KEA Max, ...
Rna 20 (7), 1090-1102, 2014
582014
The transcription factor ERG recruits CCR4–NOT to control mRNA decay and mitotic progression
X Rambout, C Detiffe, J Bruyr, E Mariavelle, M Cherkaoui, S Brohée, ...
Nature Structural & Molecular Biology 23 (7), 663-672, 2016
492016
The system can't perform the operation now. Try again later.
Articles 1–20